- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Parathyroid hormone (1-34) transglutaminase fusion protein f
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Parathyroid hormone (1-34) transglutaminase fusion protein fibrin matrix complex
| EU orphan designation number: | EU/3/06/367
|
| Active ingredient: | Parathyroid hormone (1-34) transglutaminase fusion protein fibrin matrix complex |
| Indication: | Treatment of solitary bone cysts |
| Sponsor: | Kuros Biosciences BV
Professor Bronkhorstlaan 10 G48, 3723 MB Bilthoven, Nederland |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 13/04/2006 | Orphan designation | EMEA/OD/107/05 | (2006)1640 of 11/04/2006 |
CONTACT
EU links
Directorate General Health & Consumers